Male Thyroid Cancer Survivors Face Higher CVD Risk
Age at diagnosis, sex, BMI, and thyroid-stimulating hormone suppression therapy affect CVD risk
Read MoreJun 1, 2018
Age at diagnosis, sex, BMI, and thyroid-stimulating hormone suppression therapy affect CVD risk
Read MoreJun 1, 2018
Combo of topical anesthetic plus sweet taste cuts pain response in preterm infants
Read MoreJun 1, 2018
CNN receiver operating characteristic curve had higher specificity compared with dermatologists’
Read MoreJun 1, 2018
Risk factors associated with antidepressant use include previous antianxiety, antipsychotic meds
Read MoreJun 1, 2018
Other concerns expressed by living donors include surgical, lifestyle, psychosocial impact of donation
Read MoreJun 1, 2018
Recent increase in death rates attributable to increase in injury deaths for those aged 10-19 years
Read MoreJun 1, 2018
However, no significant clinical factor was found to predict cognitive decline in older diabetes patients
Read MoreJun 1, 2018
Age 9 to 70 UV exposure damage. Image copyright 2018 AprilAge Inc. At one-month follow-up, less frequent tanning reported for facial morphing participants
Read MoreJun 1, 2018
Burden of deaths up; most patients receiving opioid analgesics use immediate-release formulations
Read MoreJun 1, 2018
197 cases of illness linked to the E. coli outbreak, five of which were fatal
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements THURSDAY, […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Variables ID’d to Predict Height […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Prompts May Up Goals-of-Care Dialogues at […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Surgery for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA Approves First Artificial Iris THURSDAY, May 31, […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Radiology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]
Read MoreMay 31, 2018
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
Read MoreMay 31, 2018
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Read MoreMay 31, 2018
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
Read More